Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice

Oncotarget

Saved in:
Bibliographic Details
Main Authors: Guo, K., Tang, J.P., Jie, L., Al-Aidaroos, A.Q.O., Hong, C.W., Tan, C.P.B., Park, J.E., Varghese, L., Feng, Z., Zhou, J., Chng, W.J., Zeng, Q.
Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
Format: Article
Published: 2014
Subjects:
Online Access:http://scholarbank.nus.edu.sg/handle/10635/115091
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-115091
record_format dspace
spelling sg-nus-scholar.10635-1150912020-09-11T04:53:52Z Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice Guo, K. Tang, J.P. Jie, L. Al-Aidaroos, A.Q.O. Hong, C.W. Tan, C.P.B. Park, J.E. Varghese, L. Feng, Z. Zhou, J. Chng, W.J. Zeng, Q. CANCER SCIENCE INSTITUTE OF SINGAPORE INSTITUTE OF MOLECULAR & CELL BIOLOGY Antibody therapy Intracellular oncoprotein PRL-3 monoclonal antibody PRL-3 mouse/human chimeric antibody Oncotarget 3 2 158-171 2014-12-12T07:10:58Z 2014-12-12T07:10:58Z 2012-02 Article Guo, K., Tang, J.P., Jie, L., Al-Aidaroos, A.Q.O., Hong, C.W., Tan, C.P.B., Park, J.E., Varghese, L., Feng, Z., Zhou, J., Chng, W.J., Zeng, Q. (2012-02). Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice. Oncotarget 3 (2) : 158-171. ScholarBank@NUS Repository. 19492553 http://scholarbank.nus.edu.sg/handle/10635/115091 NOT_IN_WOS Scopus
institution National University of Singapore
building NUS Library
country Singapore
collection ScholarBank@NUS
topic Antibody therapy
Intracellular oncoprotein
PRL-3 monoclonal antibody
PRL-3 mouse/human chimeric antibody
spellingShingle Antibody therapy
Intracellular oncoprotein
PRL-3 monoclonal antibody
PRL-3 mouse/human chimeric antibody
Guo, K.
Tang, J.P.
Jie, L.
Al-Aidaroos, A.Q.O.
Hong, C.W.
Tan, C.P.B.
Park, J.E.
Varghese, L.
Feng, Z.
Zhou, J.
Chng, W.J.
Zeng, Q.
Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice
description Oncotarget
author2 CANCER SCIENCE INSTITUTE OF SINGAPORE
author_facet CANCER SCIENCE INSTITUTE OF SINGAPORE
Guo, K.
Tang, J.P.
Jie, L.
Al-Aidaroos, A.Q.O.
Hong, C.W.
Tan, C.P.B.
Park, J.E.
Varghese, L.
Feng, Z.
Zhou, J.
Chng, W.J.
Zeng, Q.
format Article
author Guo, K.
Tang, J.P.
Jie, L.
Al-Aidaroos, A.Q.O.
Hong, C.W.
Tan, C.P.B.
Park, J.E.
Varghese, L.
Feng, Z.
Zhou, J.
Chng, W.J.
Zeng, Q.
author_sort Guo, K.
title Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice
title_short Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice
title_full Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice
title_fullStr Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice
title_full_unstemmed Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice
title_sort engineering the first chimeric antibody in targeting intracellular prl-3 oncoprotein for cancer therapy in mice
publishDate 2014
url http://scholarbank.nus.edu.sg/handle/10635/115091
_version_ 1681094923830427648